ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025
Intracranial stenosis and longitudinal progression of Alzheimer's disease pathologies.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intracranial stenosis and longitudinal progression of Alzheimer's disease pathologies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
introductionThe relationship between intracranial stenosis (ICS) and Alzheimer's disease (AD) pathologies remains unclear. We investigated whether baseline ICS is associated with longitudinal changes in amyloid beta (Aβ) and tau deposition.
methodsWe prospectively followed 180 older adults (mean age 70.06 ± 7.40 years), including cognitively normal (CN) and cognitively impaired (CI) individuals. ICS was assessed with magnetic resonance angiography. Aβ and tau deposition were measured using Pittsburgh compound B positron emission tomography (PET) and AV-1451 PET, respectively. Participants were classified into Aβ and tau analysis groups, each including both CN and CI individuals, and separate models were constructed to evaluate associations between ICS and longitudinal changes in each biomarker.
resultsThe presence of any ICS was significantly associated with greater Aβ accumulation over 4 years, while ICS in two or more arteries predicted greater tau deposition over 2 years. DISCUSSION: ICS may accelerate both Aβ and tau accumulation, supporting a vascular contribution to AD pathogenesis. HIGHLIGHTS: Intracranial stenosis at baseline predicts 4-year increase in amyloid beta deposition. Two or more stenotic intracranial arteries are linked to 2-year tau accumulation. Associations remain after adjusting for apolipoprotein E ε4 status and cognitive impairment. Intracranial atherosclerosis may accelerate both amyloid and tau accumulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.